Company Valuation: Dr. Reddy's Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 714,500 767,655 1,024,969 953,168 1,044,616 1,112,485 - -
Change - 7.44% 33.52% -7.01% 9.59% 6.5% - -
Enterprise Value (EV) 1 703,980 719,330 960,383 928,633 1,011,902 1,082,143 1,063,230 1,036,556
Change - 2.18% 33.51% -3.31% 8.97% 6.94% -1.75% -2.51%
P/E 30.4x 17.1x 18.4x 16.9x 24.4x 29.9x 22.8x 19.3x
PBR 3.76x 3.33x 3.63x 2.86x 2.78x 2.73x 2.48x 2.24x
PEG - 0.2x 0.8x 13.12x -1x -2.3x 0.7x 1.1x
Capitalization / Revenue 3.33x 3.11x 3.67x 2.93x 3.11x 3.17x 2.83x 2.57x
EV / Revenue 3.28x 2.92x 3.44x 2.85x 3.01x 3.08x 2.7x 2.4x
EV / EBITDA 13.7x 11.1x 12.1x 10.8x 15.1x 17.1x 13.2x 11.3x
EV / EBIT 20.5x 13.8x 14.8x 13.4x 21.8x 25.8x 18.4x 15.2x
EV / FCF 52.3x 15.1x 33.1x 49.1x 30.3x 30.1x 32.1x 23.9x
FCF Yield 1.91% 6.61% 3.02% 2.04% 3.3% 3.32% 3.12% 4.19%
Dividend per Share 2 6 8 8 8 8 7.482 8.373 9.13
Rate of return 0.7% 0.87% 0.65% 0.7% 0.64% 0.56% 0.63% 0.68%
EPS 2 28.34 54.18 66.92 67.78 51.42 44.6 58.47 69.11
Distribution rate 21.2% 14.8% 12% 11.8% 15.6% 16.8% 14.3% 13.2%
Net sales 1 214,391 246,697 279,164 325,535 335,933 351,357 393,731 432,374
EBITDA 1 51,400 64,559 79,481 86,236 67,048 63,155 80,731 92,091
EBIT 1 34,277 52,057 64,781 69,178 46,443 42,019 57,699 68,088
Net income 1 23,568 45,073 55,779 56,544 42,850 36,922 49,286 57,985
Net Debt 1 -10,520 -48,325 -64,586 -24,535 -32,714 -30,343 -49,256 -75,929
Reference price 2 861.08 924.30 1,231.03 1,144.05 1,254.65 1,335.40 1,335.40 1,335.40
Nbr of stocks (in thousands) 829,771 830,526 832,611 833,152 832,596 833,073 - -
Announcement Date 5/19/22 A 5/10/23 A 5/7/24 A 5/9/25 A 5/12/26 A - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
29.26x3.01x16.73x0.57% 11.45B
37.66x13.18x27.98x0.53% 1,143B
39.33x6.61x18.6x1.99% 647B
37.45x8.4x17.37x2.4% 506B
21.46x5.22x12.98x2.51% 384B
103.38x5.8x24.86x2.4% 350B
21.99x5.69x13.69x2.94% 293B
22.31x4.51x12.87x1.96% 265B
28.42x7.28x13.03x2.25% 242B
-45.78x7.1x27.53x2.07% 197B
Average 29.55x 6.68x 18.56x 1.96% 403.9B
Weighted average by Cap. 35.25x 8.34x 20.47x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Dr. Reddy's Laboratories Limited

Historical PBR trend

Valuation ratios - PBR - Dr. Reddy's Laboratories Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Dr. Reddy's Laboratories Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Dr. Reddy's Laboratories Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock
  4. Valuation Dr. Reddy's Laboratories Limited